MN Legislature

Accessibility menu

Session laws use visual text formatting such as stricken text to denote deleted language, and underlined text to denote new language. For users of the jaws screenreader it is recommended to configure jaws to use the proofreading scheme which will alter the pitch of the reading voice when reading stricken and underlined text. Instructions for configuring your jaws reader are provided by following this link.
If you can not or do not wish to configure your screen reader, deleted language will begin with the phrase "deleted text begin" and be followed by the phrase "deleted text end", new language will begin with the phrase "new text begin" and be followed by "new text end". Skip to text of Chapter 163.

Menu

Revisor of Statutes Menu

Authenticate

Pdf

1999 Minnesota Session Laws

Key: (1) language to be deleted (2) new language

                            CHAPTER 163-S.F.No. 2120 
                  An act relating to crime prevention; classifying Gamma 
                  Hydroxybutyrate as a controlled substance; amending 
                  Minnesota Statutes 1998, section 152.02, subdivision 4.
        BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: 
           Section 1.  Minnesota Statutes 1998, section 152.02, 
        subdivision 4, is amended to read: 
           Subd. 4.  [SCHEDULE III.] The following items are listed in 
        Schedule III:  
           (1) Any material, compound, mixture, or preparation which 
        contains any quantity of Amphetamine, its salts, optical 
        isomers, and salts of its optical isomers; Phenmetrazine and its 
        salts; Methamphetamine, its salts, isomers, and salts of 
        isomers; Methylphenidate; and which is required by federal law 
        to be labeled with the symbol prescribed by 21 Code of Federal 
        Regulations Section 1302.03 and in effect on February 1, 1976 
        designating that the drug is listed as a Schedule III controlled 
        substance under federal law.  
           (2) Any material, compound, mixture, or preparation which 
        contains any quantity of the following substances having a 
        potential for abuse associated with a depressant effect on the 
        central nervous system:  
           (a) Any compound, mixture, or preparation containing 
        amobarbital, secobarbital, pentobarbital or any salt thereof and 
        one or more other active medicinal ingredients which are not 
        listed in any schedule.  
           (b) Any suppository dosage form containing amobarbital, 
        secobarbital, pentobarbital, or any salt of any of these drugs 
        and approved by the food and drug administration for marketing 
        only as a suppository.  
           (c) Any substance which contains any quantity of a 
        derivative of barbituric acid, or any salt of a derivative of 
        barbituric acid, except those substances which are specifically 
        listed in other schedules:  Chlorhexadol; Glutethimide; Lysergic 
        acid; Lysergic acid amide; Methyprylon; Sulfondiethylmethane; 
        Sulfonethylmethane; Sulfonmethane. 
           (d) Gamma hydroxybutyrate, any salt, compound, derivative, 
        or preparation of gamma hydroxybutyrate, including any isomers, 
        esters, and ethers and salts of isomers, esters, and ethers of 
        gamma hydroxybutyrate whenever the existence of such isomers, 
        esters, and salts is possible within the specific chemical 
        designation.  
           (3) Any material, compound, mixture, or preparation which 
        contains any quantity of the following substances having a 
        potential for abuse associated with a stimulant effect on the 
        central nervous system:  
           (a) Benzphetamine 
           (b) Chlorphentermine 
           (c) Clortermine 
           (d) Mazindol 
           (e) Phendimetrazine.  
           (4) Nalorphine.  
           (5) Any material, compound, mixture, or preparation 
        containing limited quantities of any of the following narcotic 
        drugs, or any salts thereof:  
           (a) Not more than 1.80 grams of codeine per 100 
        milliliters or not more than 90 milligrams per dosage unit, with 
        an equal or greater quantity of an isoquinoline alkaloid of 
        opium.  
           (b) Not more than 1.80 grams of codeine per 100 
        milliliters or not more than 90 milligrams per dosage unit, with 
        one or more active, nonnarcotic ingredients in recognized 
        therapeutic amounts.  
           (c) Not more than 300 milligrams of dihydrocodeinone per 
        100 milliliters or not more than 15 milligrams per dosage unit, 
        with a fourfold or greater quantity of an isoquinoline alkaloid 
        of opium.  
           (d) Not more than 300 milligrams of dihydrocodeinone per 
        100 milliliters or not more than 15 milligrams per dosage unit, 
        with one or more active, nonnarcotic ingredients in recognized 
        therapeutic amounts. 
           (e) Not more than 1.80 grams of dihydrocodeine per 100 
        milliliters or not more than 90 milligrams per dosage unit, with 
        one or more active, nonnarcotic ingredients in recognized 
        therapeutic amounts.  
           (f) Not more than 300 milligrams of ethylmorphine per 100 
        milliliters or not more than 15 milligrams per dosage unit, with 
        one or more active, nonnarcotic ingredients in recognized 
        therapeutic amounts.  
           (g) Not more than 500 milligrams of opium per 100 
        milliliters or per 100 grams, or not more than 25 milligrams per 
        dosage unit, with one or more active, nonnarcotic ingredients in 
        recognized therapeutic amounts. 
           (h) Not more than 50 milligrams of morphine per 100 
        milliliters or per 100 grams with one or more active, 
        nonnarcotic ingredients in recognized therapeutic amounts. 
           Sec. 2.  [EFFECTIVE DATE.] 
           Section 1 is effective August 1, 1999, and applies to 
        crimes committed on or after that date. 
           Presented to the governor May 11, 1999 
           Signed by the governor May 13, 1999, 1:32 p.m.

700 State Office Building, 100 Rev. Dr. Martin Luther King Jr. Blvd., St. Paul, MN 55155 ♦ Phone: (651) 296-2868 ♦ TTY: 1-800-627-3529 ♦ Fax: (651) 296-0569